Researchers have developed an RNA-seq method for investigating drug-resistant infections, and we got the inside scoop!

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

Drug developers' dreams of silencing RNA as a way to step in front of a range of diseases have not lived up to early-day hype ...

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa.

BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...

The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for ...

PepGen has previously faced an FDA clinical hold on the investigational new drug application of PGN-ENO51 in the Phase II ...

Skyhawk’s drug discovery and development platform generates ... The approach is to develop small-molecule drugs that can correct RNA mis-splicing, leading to loss of RNA expression by exon ...

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.

There is no dearth of treatments that claim to hold back ageing. No magic pill exists that is proven to work - but we do know of some that might. It is an ancient dream of humankind - the dream of ...

A new review article published in Genes & Diseases explores the intricate relationship between non-coding RNAs and oxidative stress in cancer progression shedding new light on the mechanisms that ...